Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Additional Paid in Capital. Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid in Capital.	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Accumulated Other Comprehensive Income (Loss) Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Income (Loss)	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Total
Beginning balance at Dec. 31, 2022	$ 19,992	$ 19,992	$ 155,095	$ 155,095	$ (4,452)	$ 275,974	$ 280,426	$ (98,641)	$ (98,641)	$ (4,452)	$ 352,420	$ 356,872
Net income							17,290					17,290
Other comprehensive income (loss)									(2,101)			(2,101)
Common stock repurchased		(187)		(3,127)								(3,314)
Common stock dividends							(7,425)					(7,425)
Share-based compensation expense		18		797								815
Vesting of restricted stock		92		(92)
Ending balance at Jun. 30, 2023		19,915		152,673			285,839		(100,742)			357,685
Beginning balance at Mar. 31, 2023		20,067		154,818			280,540		(96,307)			359,118
Net income							9,104					9,104
Other comprehensive income (loss)									(4,435)			(4,435)
Common stock repurchased		(170)		(2,783)								(2,953)
Common stock dividends							(3,805)					(3,805)
Share-based compensation expense		18		638								656
Ending balance at Jun. 30, 2023		19,915		152,673			285,839		(100,742)			357,685
Beginning balance at Dec. 31, 2023		19,734		150,343			272,705		(73,655)			369,127
Net income							12,640					12,640
Other comprehensive income (loss)									(1,374)			(1,374)
Common stock repurchased		(7)		(149)								(156)
Common stock dividends							(7,725)					(7,725)
Share-based compensation expense				714								714
Vesting of restricted stock		51		(51)
Ending balance at Jun. 30, 2024		19,778		150,857			277,620		(75,029)			373,226
Beginning balance at Mar. 31, 2024		19,777		150,741			275,374		(74,256)			371,636
Net income							6,208					6,208
Other comprehensive income (loss)									(773)			(773)
Common stock repurchased				(4)								(4)
Common stock dividends							(3,962)					(3,962)
Share-based compensation expense				121								121
Vesting of restricted stock		1		(1)
Ending balance at Jun. 30, 2024		$ 19,778		$ 150,857			$ 277,620		$ (75,029)			$ 373,226